Atlas Trials

Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

Clinical trial NCT04882293 · UNKNOWN

Trial details

NCT number
NCT04882293
Sponsor
Laboratorios Silanes S.A. de C.V.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Dyslipidemia Associated With Type II Diabetes Mellitus
Start date
2022-02-15
Primary completion
2022-05-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.